Alliancebernstein L.P. Sells 147,853 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alliancebernstein L.P. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,237,998 shares of the medical equipment provider's stock after selling 147,853 shares during the quarter. Intuitive Surgical comprises about 0.8% of Alliancebernstein L.P.'s holdings, making the stock its 18th largest position. Alliancebernstein L.P. owned 1.19% of Intuitive Surgical worth $2,212,065,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of ISRG. Bennett Selby Investments LP boosted its stake in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC boosted its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the last quarter. LVW Advisors LLC raised its stake in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Remove Ads

Intuitive Surgical Trading Down 6.7 %

ISRG stock traded down $32.90 during midday trading on Friday, reaching $461.71. 1,764,326 shares of the company's stock traded hands, compared to its average volume of 1,533,826. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock's 50-day moving average is $547.83 and its 200 day moving average is $532.58. The stock has a market cap of $164.45 billion, a P/E ratio of 71.88, a PEG ratio of 5.85 and a beta of 1.55.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ISRG shares. Robert W. Baird reduced their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, March 18th. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.